Quarterly report pursuant to Section 13 or 15(d)

Fair Value Measurements (Tables)

v3.24.2.u1
Fair Value Measurements (Tables) - Warrants to Purchase Common Stock [Member]
6 Months Ended
Jun. 30, 2024
Schedule of revaluation of warrant liability

​

​

​

​

​

​

​

Warrants

($ in thousands)

    

liabilities

Balance at December 31, 2023

​

$

886

Change in fair value of common stock warrants - Avenue

​

​

(139)

Change in fair value of common stock warrants - Checkpoint

​

​

—

Change in fair value of placement agent warrants - Urica

​

​

(24)

Exercise of common stock warrants - Avenue

​

​

(400)

Exchange of common stock warrants - Urica

​

​

(151)

Balance at June 30, 2024

​

$

172

Checkpoint Common Stock Warrants  
Summary of the Weighted average Significant Unobservable Inputs

​

​

​

​

​

​

​

​

​

​

​

​

June 30, 

​

December 31,

​

​

Checkpoint Warrants

​

2024

​

2023

​

​

Exercise price

​

$

5.41

​

$

5.41

​

​

Volatility

​

​

106.9

%

​

96.4

%

​

Expected life in years

​

​

3.5

​

​

4.0

​

​

Risk-free rate

​

​

4.5

%

​

3.8

%

​

Avenue Therapeutics, Inc [Member]  
Schedule of revaluation of warrant liability

​

​

​

​

​

​

​

Avenue

​

​

Warrant

($ in thousands)

​

Liability

Avenue common stock warrant liabilities at December 31, 2023

​

$

586

Exercise of Avenue common warrants

​

​

(400)

Change in fair value of common stock warrant liabilities

​

​

(139)

Avenue common stock warrant liabilities at June 30, 2024

​

$

47

Summary of the Weighted average Significant Unobservable Inputs

​

​

​

​

​

​

​

​

​

​

​

June 30, 

​

​

December 31

​

​

​

​

2024

​

​

2023

​

​

Stock price

​

$ 3.50

​

​

$ 12.00

​

​

Risk-free interest rate

    

4.52

%  

​

3.84

%  

​

Expected dividend yield

 

—

 

​

—

 

​

Expected term in years

 

3.3

 

​

3.8

 

​

Expected volatility

 

160

%  

​

148

%  

​

Urica  
Summary of the Weighted average Significant Unobservable Inputs

​

​

​

​

​

​

​

December 31,

​

​

2023

Risk-free interest rate

    

3.93

%  

Expected dividend yield

 

—

 

Expected term in years

 

0.5

 

Expected volatility

 

153.6

%  

​